1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Belgium >
  5. Watson Pharmaceuticals Acquires Uteron Pharma SA

M&A Deal Summary

Watson Pharmaceuticals Acquires Uteron Pharma SA

On January 23, 2013, Watson Pharmaceuticals acquired medical products company Uteron Pharma SA for 150M USD

Acquisition Highlights
  • This is Watson Pharmaceuticals’ 4th transaction in the Medical Products sector.
  • This is Watson Pharmaceuticals’ 4th largest (disclosed) transaction.
  • This is Watson Pharmaceuticals’ 1st transaction in Belgium.

M&A Deal Summary
Date 2013-01-23
Target Uteron Pharma SA
Sector Medical Products
Buyer(s) Watson Pharmaceuticals
Deal Type Add-on Acquisition
Deal Value 150M USD

Target

Uteron Pharma SA

Grâce-Hollogne, Belgium
Uteron Pharma SA is a development-based company dedicated to female healthcare. Uteron has a diversified portfolio of innovative products in different stages of development. The product development portfolio includes a hormonal IUD, a next generation oral contraceptives containing natural estrogen, a new generation of biochemical tests that will significantly increase in-vitro fertilization success rates, and pharmacologic treatments for cervical dysplasia.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Watson Pharmaceuticals

Florham Park, New Jersey, United States
Category Company
Founded 1931
Sector Medical Products
Employees1,325
DESCRIPTION

Watson Pharmaceuticals, Inc.,is a specialty pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

DEAL STATS #
Overall 9 of 9
Sector: Medical Products M&A 4 of 4
Type: Add-on Acquisition M&A Deals 5 of 5
Country: Belgium M&A 1 of 1
Year: 2013 M&A 1 of 1
Size (of disclosed) 4 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-31 Pharmaco Hf.

Hafnarfirdi,, Iceland

Pharmaco Hf. engages in the development, manufacture, and sale of generic pharmaceuticals.

Buy €4.3B
Mergr

Solution for

Product

Company

Legal